BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a restructuring...
BioNTech shares sank yesterday as disappointing Q1 results prompted layoffs. But long-term investors still have ample reasons to load up on BNTX stock today.
Barchart Research What to Expect from BNTX Earnings BNTX Generated May 4, 2026 Current Price $99.35 EPS Estimate $$-2.52 Consensus Rating Strong Buy Average Move 4.33% BioNTech's Seventeen Billion Euro...
BioNTech shares are crashing as the company posted a disappointing Q4 release and announced cofounders departure by the end of 2026. Here’s why BNTX stock is still worth buying today.
Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech. Have the good days finally come to an end?
In a report released today, Geoff Meacham from Citi maintained a Buy rating on BioNTech SE. The company’s shares opened today at $101.91.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...
TD Cowen analyst Yaron Werber maintained a Hold rating on BioNTech SE today and set a price target of $120.00. The company’s shares closed yesterday at $102.21.Elevate Your Investing Strategy: Take advantage...
In a report released on September 30, Evan Seigerman from BMO Capital assigned a Buy rating to BioNTech SE, with a price target of $143.00. The company’s shares closed yesterday at $102.21.Elevate Your...
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END